Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supreme Court Held that Department of Health and Human Services set unlawful Medicare reimbursement rates for hospitals in the 340B Drug Pricing Program in 2018 and 2019, decision did not address how the violation should be remedied and remanded case to lower courts
The Supreme Court issued a long-awaited victory to 340B hospitals this week, when it held in American Hospital Association et al. v. Becerra et al. that the Department of Health and...
The Nearly 30 percent reduction in Medicare reimbursement for outpatient drug payments for hospitals participating in the 340B drug pricing program implemented in 2018 and 2019 were unlawful.HHS does not have the authority to reduce reimbursement rates for 340B hospitals
Today, the Supreme Court ruled that the U.S. Department of Health and Human Services (HHS) does not have the discretion to change 340B Drug Pricing Program reimbursement rates without gathering data on what hospitals pay for outpatient drugs. ASHP has aggressively been advocating to safeguard the 340B program and address this issue since 2018 .
The Supreme Court ruled on Wednesday in favor of a coalition of nonprofit hospitals seeking to restore billions of dollars that were cut by the government from annual Medicare reimbursements dating as far back as 2018.